TC Biopharm (Holdings) Plc (TCBP) Income Annual - Discounting Cash Flows
TCBP
TC Biopharm (Holdings) Plc
TCBP (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
Report Filing 2024-11-25 2024-04-29 2023-05-01 2022-05-13 2020-12-31 2019-12-31
Revenue 0 0 3.84 1.98 1.98 3.43
Cost of Revenue 0 0 0 0 0 0
Gross Profit 0 0 3.84 1.98 1.98 3.43
Operating Expenses 12.05 14.24 15.93 9.27 8.87 10.07
Research & Development 5.93 7.77 7.59 6.16 6.68 8.61
Selling, General and Administrative 6.52 6.87 8.74 3.11 2.21 3.01
Other Operating Expenses -0.402 -0.402 -0.402 0 -0.021 -1.56
Operating Income -12.05 -14.24 -12.08 -7.29 -6.89 -6.64
Net Non-Operating Interest 0.06 0.083 -6.75 -3.44 -0.291 -0.254
Interest Income 0.06 0.083 0 0 0.001 0.022
Interest Expense 0 0 6.75 3.44 0.292 0.275
Equity & Other Income/(Expense) -0.184 7.16 15.8 -4.26 0.548 0
Income Before Tax -12.17 -7 -3.03 -14.98 -6.63 -6.89
Income Tax Expense -0.605 -1.09 -1.72 -1.41 -1.17 -0.826
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0
Net Income -11.57 -5.91 -1.31 -13.58 -5.46 -6.07
Depreciation and Amortization 0.536 0.63 0.762 0.812 0.879 0.722
EBITDA -11.51 -13.61 -11.32 -6.48 -6.01 -5.92
Earnings Per Share (EPS) -8.42 -9.56 -19.12 -82,488 -124 -138
Diluted Earnings Per Share -8.42 -9.56 -19.12 -82,488 -124 -138
Weighted Average Shares Outstanding 6.49 0.618 0.069 0.039 0.056 0.056
Diluted Weighted Average Shares Outstanding 6.49 0.618 0.069 0.039 0.056 0.056
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program